Dr. Christopher J. Ballard, MD

Dr. Ballard practices at Suncoast Skin Solutions in Largo, Florida.

Dr. Ballard's NPI, 1164679668, was assigned on August 26, 2008. Dr. Ballard graduated from University of Miami, Miller School of Medicine in 2007. Dr. Ballard holds Florida license ME109317.

Dr. Ballard's primary practice is Suncoast Skin Solutions, at 11200 Seminole Blvd, Largo, FL 33778 in Pinellas County. The practice phone is (813) 321-1786.

Dr. Ballard's primary practice is Suncoast Skin Solutions in Largo, Florida. The medical group on file is Suncoast Skin Solutions. Dmand AI also links Dr. Ballard to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ballard practices. Vendor and product names are available with a free account.

Dermatology is Dr. Ballard's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ballard is board certified in dermatology by the American Board of Dermatology. Dr. Ballard is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, joint cyst and minor injury to a limb among the conditions Dr. Ballard treats.

CMS data shows 4,466 Medicare services from Dr. Ballard across 18 procedure codes in 2024, for 690 Medicare patients. Medicare paid $158,456 for them. Every service was in an office.

CMS counts 690 Medicare patients who saw Dr. Ballard in 2024. The largest group is 65 to 74, with 336 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ballard's median patient age at 72, with 47% women.

In 2024, Dr. Ballard wrote 937 Medicare Part D claims for 482 patients. 99% of them were for generic drugs. CMS names the drug for 826 of them, across 13 drugs with 11 or more claims each, at $15,485 in total drug cost. In 2023, CMS named 859 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ballard for performance year 2024, reported individually. Dr. Ballard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,575 procedures of removal of skin lesions by Dr. Ballard, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Ballard, published from 2009 to 2011. The most frequent topics are Skin Neoplasms, Carcinoma, Basal Cell and Lasers, Dye. Dr. Ballard has published most often in Dermatol Surg. Dr. Ballard's most frequent co-authors are Keyvan Nouri, MD, George W. Elgart, MD and Robert S. Kirsner, MD.

CMS Open Payments shows 46 general payments to Dr. Ballard from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $210.

Dmand AI lists 2 awards for Dr. Ballard, most recently CMS Stage 1 2012 in 2011.

Dr. Ballard graduated from University of Miami, Miller School of Medicine in 2007. Dr. Ballard is a member of AAD.

Dr. Ballard is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.